Eris Lifesciences to hold UK investor roadshow next week

Eris Lifesciences Limited informed the BSE Limited and National Stock Exchange of India Limited on September 2, 2025, about a scheduled in-person group meeting with investors in the UK. This engagement is part of a non-deal roadshow organized by Investec Capital, with meetings slated to take place from September 8, 2025, to September 9, 2025.

The company clarified that the schedule is indicative and subject to changes. During these interactions, Eris Lifesciences intends to refer to publicly available documents for discussions.

Eris Lifesciences stated that no unpublished price sensitive information will be discussed during these investor meetings, ensuring compliance with regulatory guidelines. The intimation was signed by Milind Talegaonkar, company secretary & compliance officer.